IL10 and colitis: As shown in Figure 3B, compared with the mice treated with ManLAM‐WT B cells, colitis scores were significantly higher in the mice subjected to the treatment with WT B, IL‐10−/− B and ManLAM‐treated IL‐10−/− B cells, mostly due to typical inflammatory changes including goblet cell loss and crypt damage.